Detalhe da pesquisa
1.
The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer.
Diagnostics (Basel)
; 13(8)2023 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37189572
2.
AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine.
Pan Afr Med J
; 41: 59, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35317488
3.
Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients.
Cancer Genet
; 260-261: 41-45, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922269
4.
Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et).
Front Med (Lausanne)
; 9: 991873, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36160152
5.
Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer.
Front Oncol
; 11: 795242, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35223454
6.
Evaluation of glutathione S-transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer.
Mol Genet Genomic Med
; 6(5): 819-827, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043549